Literature DB >> 16404616

Study on improving the selectivity of compounds that inhibit two PI3Ks (gamma and delta).

Rong-Ren Kuang1, Feng Qian, Zhong Li, Dong-Zhi Wei.   

Abstract

A desirable characteristic of PI3K inhibitors is their selectivity. Up to now, there has been no report that describes the 3 D-structure differences between two PI3Ks (delta and gamma) and applies them to designing selective compounds. In the present study, we used an approach combining protein-structure modeling, GRID/PCA (Principal Component Analysis) and docking methods to investigate the detail interactions of the two PI3Ks with various chemical groups. At first, we constructed a 3 D-model of the PI3Kdelta catalytic subunit with the program Modeller7.0 based on the high resolution X-ray structure of the PI3Kgamma catalytic subunit, and then employed GRID and PCA to reveal the most relevant structural and physicochemical differences between the two PI3Ks related to their selectivity. As a result, the analysis unveiled the most important regions on the two PI3Ks that should be taken into account for the design of selective inhibitors. Finally, based on activity data of 10 PI3Kdelta-selective compounds, a docking study validated the results of the GRID/PCA method, which suggested that the approach could provide clear guidelines for selective drug design.

Mesh:

Substances:

Year:  2006        PMID: 16404616     DOI: 10.1007/s00894-005-0069-8

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  25 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Signaling by distinct classes of phosphoinositide 3-kinases.

Authors:  B Vanhaesebroeck; M D Waterfield
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

3.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.

Authors:  T Sasaki; J Irie-Sasaki; R G Jones; A J Oliveira-dos-Santos; W L Stanford; B Bolon; A Wakeham; A Itie; D Bouchard; I Kozieradzki; N Joza; T W Mak; P S Ohashi; A Suzuki; J M Penninger
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

Review 4.  PI3-kinase inhibition: a target for drug development?

Authors:  R C Stein; M D Waterfield
Journal:  Mol Med Today       Date:  2000-09

Review 5.  Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases.

Authors:  Snezana Djordjevic; Paul C Driscoll
Journal:  Trends Biochem Sci       Date:  2002-08       Impact factor: 13.807

6.  The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000.

Authors:  A Bairoch; R Apweiler
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

7.  Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction.

Authors:  Z Li; H Jiang; W Xie; Z Zhang; A V Smrcka; D Wu
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

8.  Verification of protein structures: patterns of nonbonded atomic interactions.

Authors:  C Colovos; T O Yeates
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

9.  Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities.

Authors:  Lazaros C Foukas; Nathalie Daniele; Chariklia Ktori; Karen E Anderson; Jorgen Jensen; Peter R Shepherd
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

10.  Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

Authors:  E Hirsch; V L Katanaev; C Garlanda; O Azzolino; L Pirola; L Silengo; S Sozzani; A Mantovani; F Altruda; M P Wymann
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

View more
  3 in total

1.  Molecular dynamics and integrated pharmacophore-based identification of dual [Formula: see text] inhibitors.

Authors:  Maninder Kaur; Pankaj Kumar Singh; Manjinder Singh; Renu Bahadur; Om Silakari
Journal:  Mol Divers       Date:  2017-11-14       Impact factor: 2.943

2.  Dissecting isoform selectivity of PI3K inhibitors: the role of non-conserved residues in the catalytic pocket.

Authors:  Mark Frazzetto; Cenk Suphioglu; Jiuxiang Zhu; Oleg Schmidt-Kittler; Ian G Jennings; Susan L Cranmer; Shaun P Jackson; Kenneth W Kinzler; Bert Vogelstein; Philip E Thompson
Journal:  Biochem J       Date:  2008-09-15       Impact factor: 3.857

3.  Thiazolidinedione-based PI3Kα inhibitors: an analysis of biochemical and virtual screening methods.

Authors:  Jo-Anne Pinson; Oleg Schmidt-Kittler; Jiuxiang Zhu; Ian G Jennings; Kenneth W Kinzler; Bert Vogelstein; David K Chalmers; Philip E Thompson
Journal:  ChemMedChem       Date:  2011-01-04       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.